| Financial Year |
March 31 2023 |
| Monetary Funds |
1,052,337,331.01 |
| Held-for-trading Financial Assets |
106,469,384.88 |
| Notes Receivable |
8,280,284.77 |
| Accounts Receivable |
95,247,914.64 |
| Advances to Suppliers |
6,851,367.79 |
| Other Receivables |
1,892,066.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
138,913,104.01 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
29,249,043.72 |
| Total Current Assets |
1,496,352,960.07 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,184,699.87 |
| Investment Properties |
-- |
| Fixed Assetes |
419,840,796.93 |
| Under-construction Projects |
70,872,768.37 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
170,370,361.56 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
10,173,913.62 |
| Other Non-Current Assets |
19,157,987.00 |
| Sub-Total of Non-Current Assets |
703,813,603.82 |
| Total Assets |
2,200,166,563.89 |
| Short-Term Loans |
4,412,365.81 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
85,721,662.44 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,559,811.16 |
| Taxes Payable |
16,408,538.64 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
19,283,284.04 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,435,216.59 |
| Other Current Liabilities |
14,526,032.90 |
| Sub-Total of Current Liabilities |
183,559,923.11 |
| Long-term Loans |
7,997,156.86 |
| Bonds Payable |
383,116,187.31 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
432,946,526.67 |
| Total Liabilities |
616,506,449.78 |
| Paid-In Capital(Or Share Stock) |
117,871,000.00 |
| Capital Surplus |
912,147,860.40 |
| Surplus Reserve |
56,742,826.57 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
344,957,343.90 |
| Minority Stockholder's Interest |
2,995,006.40 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,580,665,107.71 |
| Owner's Equity（Stockholder's Equity） |
1,583,660,114.11 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,200,166,563.89 |
